345505 <common-name>[(3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] 2-morpholin-4-ylacetate</common-name> <description>[(3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] 2-morpholin-4-ylacetate is a chemical compound with the formula C26H41NO8. It has an average molecular weight of 495.60 g/mol.</description> <cas nil="true"/> <pubchem-id>3064748</pubchem-id> <chemical-formula>C26H41NO8</chemical-formula> <weight>495.6</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T08:18:07Z</created-at> <updated-at type="dateTime">2026-08-31T08:18:07Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1(CCC(C2(C1C(C(C3(C2(C(=O)CC(O3)(C)C=C)O)C)OC(=O)CN4CCOCC4)O)C)O)C</moldb-smiles> <moldb-formula>C26H41NO8</moldb-formula> <moldb-inchi>InChI=1S/C26H41NO8/c1-7-23(4)14-17(29)26(32)24(5)16(28)8-9-22(2,3)20(24)19(31)21(25(26,6)35-23)34-18(30)15-27-10-12-33-13-11-27/h7,16,19-21,28,31-32H,1,8-15H2,2-6H3/t16-,19-,20-,21-,23-,24-,25+,26-/m0/s1</moldb-inchi> <moldb-inchikey>QNMQLJFIWYEVRO-WUTAMHGZSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">495.2832173</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>0.7</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM341398</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>[(3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] 2-morpholin-4-ylacetate</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Lipids and lipid-like molecules</superklass> <klass>Prenol lipids</klass> <subklass>Triterpenoids</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0295862</sync-id> <structure-inchikey>QNMQLJFIWYEVRO-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>800040000000000080010000000000000000000000000000040000000020000000000000000000000000000000000000000000000000001000000000100000008000000000000020800000000300000004040000008080000000090000000000008000000020000001020108220000000000000000100200000048000100000000000200000020200000000000000000800000400020000000008004000000000200082000040000000040000000018100000000000000211000000000000000000000040000000000000000000020000000000000010000080000000041000000080000000400000800000000000100000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAjAAAAJgAAAIABBgBgAAAAAQMGACAAAAAE BgBgAAAAAgIGAGAAAAACAgYAYAAAAAMBBgAgAAAABAYAYAAAAAMBBgBgAAAA AwEGAGAAAAADAQYAIAAAAAQGACAAAAAEBgAoAAAAAwQIACgAAAADAgYAYAAA AAICBgAgAAAABAgAIAAAAAIGAGAAAAABAwYAaAAAAAMDAQYAaAAAAAMCAggA YAAAAAEBBgBgAAAAAQMIACgAAAADAgYAKAAAAAMECAAoAAAAAwIGAGAAAAAC AgcAIAAAAAMGAGAAAAACAgYAYAAAAAICCAAgAAAAAgYAYAAAAAICBgBgAAAA AgIIAGAAAAABAQYAYAAAAAEDCABgAAAAAQEGAGAAAAABAwsAAQABAgACAwAD BAAEBQAFBgAGBwAHCAAICQAJCgAKCwALDAgCCw0ADQ4ADg8ADhAADhEAERII AgoTAAkUAAgVABUWIBYXKAIWGAAYGQAZGgAaGwAbHAAcHQAdHgAHHwAFIAAE IQABIgAGAQAKBQAPCQAeGQBCBAAAAAYBBgUEAwIGBwgJCgUGBgsNDg8JCgYa GxwdHhkXBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:44:32Z</structure-indexed-at> </compound>